Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
1028
-
Total 13F shares, excl. options
-
114M
-
Shares change
-
-4.26M
-
Total reported value, excl. options
-
$32.4B
-
Value change
-
-$1.19B
-
Put/Call ratio
-
1.23
-
Number of buys
-
383
-
Number of sells
-
-504
-
Price
-
$283.68
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q3 2020
1,190 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q3 2020.
BIOGEN INC. - Common Stock (BIIB) has 1,028 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 114M shares
of 147M outstanding shares and own 77.59% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (15.7M shares), VANGUARD GROUP INC (12.3M shares), STATE STREET CORP (7.52M shares), WELLINGTON MANAGEMENT GROUP LLP (4.86M shares), Clearbridge Investments, LLC (4.02M shares), RENAISSANCE TECHNOLOGIES LLC (3.82M shares), GEODE CAPITAL MANAGEMENT, LLC (2.89M shares), NORTHERN TRUST CORP (2.38M shares), Bank of New York Mellon Corp (2.31M shares), and AQR CAPITAL MANAGEMENT LLC (2.22M shares).
This table shows the top 1028 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.